NAS:LMAT (USA) Also trade in: Germany

LeMaitre Vascular Inc

$ 26.6 0 (0%)
Volume: 83,043 Avg Vol (1m): 144,909
Market Cap $: 523.25 Mil Enterprise Value $: 482.49 Mil
P/E (TTM): 23.92 P/B: 4.04
Earnings Power Value 11.08
Net Current Asset Value 3.38
Tangible Book 4.46
Projected FCF 12.98
Median P/S Value 10.2
Graham Number 10.55
Peter Lynch Value 27.75
DCF (FCF Based) 0
DCF (Earnings Based) 0
1Y (-%)

Financial Strength : 9/10

GuruFocus Financial Strength Rank measures how strong a company's financial situation is . It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
Current vs industry vs history
Cash-to-Debt 7.08
Cash-To-Debt ranked higher than
91.22% of 205 companies
in the Medical Instruments & Supplies industry.
Industry Max: 10000, Med: 1.74, Min: 0.01
LMAT: 7.08
Ranked among companies with meaningful Cash-To-Debt only.
Cash-To-Debt range over the past 10 years
Min: 0.1, Med: 10000, Max: 10000
Current: 7.08
0.1
10000
Equity-to-Asset 0.83
Equity-to-Asset ranked higher than
88.27% of 196 companies
in the Medical Instruments & Supplies industry.
Industry Max: 2.26, Med: 0.6, Min: -5.6
LMAT: 0.83
Ranked among companies with meaningful Equity-to-Asset only.
Equity-to-Asset range over the past 10 years
Min: 0.4, Med: 0.85, Max: 0.9
Current: 0.83
0.4
0.9
Debt-to-Equity 0.05
Debt-to-Equity ranked lower than
100.00% of 142 companies
in the Medical Instruments & Supplies industry.
Industry Max: 3.57, Med: 0.37, Min: 0.01
LMAT: 0.05
Ranked among companies with meaningful Debt-to-Equity only.
Debt-to-Equity range over the past 10 years
Min: 0, Med: 0, Max: 0.39
Current: 0.05
0
0.39
Debt-to-EBITDA 0.21
Debt-to-EBITDA ranked lower than
100.00% of 109 companies
in the Medical Instruments & Supplies industry.
Industry Max: 66.68, Med: 1.88, Min: 0.02
LMAT: 0.21
Ranked among companies with meaningful Debt-to-EBITDA only.
Debt-to-EBITDA range over the past 10 years
Min: 0.05, Med: 0.05, Max: 0.21
Current: 0.21
0.05
0.21
Interest Coverage 10154.00
Interest Coverage ranked higher than
65.69% of 137 companies
in the Medical Instruments & Supplies industry.
Industry Max: 21607070, Med: 63.92, Min: 0.47
LMAT: 10154
Ranked among companies with meaningful Interest Coverage only.
Interest Coverage range over the past 10 years
Min: 147.38, Med: 1341.1, Max: 10367.5
Current: 10154
147.38
10367.5
Piotroski F-Score 3
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 14.19
DISTRESS
GREY
SAFE
Beneish M-Score -2.54
Not Manipulator
Manipulator
WACC vs ROIC %
ROIC 20.98%
WACC 11.7%

Profitability & Growth : 6/10

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.
Current vs industry vs history
Operating Margin % 18.79
Operating Margin ranked higher than
85.57% of 201 companies
in the Medical Instruments & Supplies industry.
Industry Max: 239.27, Med: 4.41, Min: -219137.5
LMAT: 18.79
Ranked among companies with meaningful Operating Margin only.
Operating Margin range over the past 10 years
Min: 7, Med: 10.63, Max: 20.92
Current: 18.79
7
20.92
Net Margin % 20.92
Net Margin ranked higher than
85.07% of 201 companies
in the Medical Instruments & Supplies industry.
Industry Max: 182.67, Med: 4.18, Min: -221450
LMAT: 20.92
Ranked among companies with meaningful Net Margin only.
Net Margin range over the past 10 years
Min: 3.14, Med: 7.71, Max: 21.73
Current: 20.92
3.14
21.73
ROE % 18.14
ROE ranked higher than
79.80% of 198 companies
in the Medical Instruments & Supplies industry.
Industry Max: 95.67, Med: 5.43, Min: -1452.51
LMAT: 18.14
Ranked among companies with meaningful ROE only.
ROE range over the past 10 years
Min: 3.4, Med: 8.45, Max: 19.12
Current: 18.14
3.4
19.12
ROA % 15.61
ROA ranked higher than
89.81% of 206 companies
in the Medical Instruments & Supplies industry.
Industry Max: 46.82, Med: 1.85, Min: -307.58
LMAT: 15.61
Ranked among companies with meaningful ROA only.
ROA range over the past 10 years
Min: 2.87, Med: 7.08, Max: 16.42
Current: 15.61
2.87
16.42
ROC (Joel Greenblatt) % 69.73
ROC (Joel Greenblatt) ranked higher than
85.78% of 204 companies
in the Medical Instruments & Supplies industry.
Industry Max: 387.24, Med: 9.63, Min: -114200
LMAT: 69.73
Ranked among companies with meaningful ROC (Joel Greenblatt) only.
ROC (Joel Greenblatt) range over the past 10 years
Min: 20.05, Med: 29.06, Max: 72.74
Current: 69.73
20.05
72.74
3-Year Total Revenue Growth Rate 10.40
3-Year Revenue Growth Rate ranked higher than
51.76% of 170 companies
in the Medical Instruments & Supplies industry.
Industry Max: 1424.9, Med: 4.1, Min: -100
LMAT: 6.8
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
3-Year Revenue Growth Rate range over the past 10 years
Min: -4.9, Med: 5.6, Max: 21.4
Current: 6.8
-4.9
21.4
3-Year Total EBITDA Growth Rate 30.30
3-Year EBITDA Growth Rate ranked higher than
79.35% of 155 companies
in the Medical Instruments & Supplies industry.
Industry Max: 426.6, Med: 10, Min: -759
LMAT: 26
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
3-Year EBITDA Growth Rate range over the past 10 years
Min: 0, Med: 16.2, Max: 40.9
Current: 26
0
40.9
3-Year EPS w/o NRI Growth Rate 39.10
3-Year EPS w/o NRI Growth Rate ranked higher than
84.52% of 155 companies
in the Medical Instruments & Supplies industry.
Industry Max: 253, Med: 12.9, Min: -782.7
LMAT: 39.1
Ranked among companies with meaningful 3-Year EPS w/o NRI Growth Rate only.
3-Year EPS w/o NRI Growth Rate range over the past 10 years
Min: 0, Med: -45, Max: 55.2
Current: 39.1
0
55.2

» LMAT's 30-Y Financials

Financials (Next Earnings Date: 2019-07-26)

Guru Trades Click for details

» Details

Insider Trades

SEC Filings

Gurus Latest Trades with NAS:LMAT

» Interactive Chart

Peter Lynch Chart

Business Description

Industry Medical Instruments & Equipment » Medical Instruments & Supplies    NAICS : 339112    SIC : 3841
Compare NAS:OSUR SZSE:300677 SHSE:603309 XSWX:CLTN SZSE:300358 XKRX:145720 XKRX:039840 XKLS:7106 SHSE:603987 XKRX:048260 OSTO:ALIF B SZSE:300753 NAS:ATRS AMEX:TRXC TSE:7749 TSE:4218 ROCO:6491 SZSE:002432 SZSE:300061 NAS:ANGO
Traded in other countries LHU.Germany
Address 63 Second Avenue, Burlington, MA, USA, 01803
LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are primarily used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes the largest proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches, and vessel closure systems. LeMaitre generates the majority of its revenue in the United States. Sales in Germany also contribute a significant proportion of total revenue.

Ratios

Current vs industry vs history
PE Ratio (TTM) 23.92
PE Ratio ranked lower than
75.20% of 125 companies
in the Medical Instruments & Supplies industry.
Industry Max: 1012.86, Med: 31.7, Min: 0.65
LMAT: 23.92
Ranked among companies with meaningful PE Ratio only.
PE Ratio range over the past 10 years
Min: 15.93, Med: 35.71, Max: 125
Current: 23.92
15.93
125
Forward PE Ratio 31.65
Forward P/E ranked lower than
87.50% of 40 companies
in the Medical Instruments & Supplies industry.
Industry Max: 80, Med: 26.32, Min: 12.3
LMAT: 31.65
Ranked among companies with meaningful Forward P/E only.
N/A
PE Ratio without NRI 23.92
PE without NRI ranked lower than
73.98% of 123 companies
in the Medical Instruments & Supplies industry.
Industry Max: 1012.86, Med: 9999, Min: 0.65
LMAT: 23.92
Ranked among companies with meaningful PE without NRI only.
PE without NRI range over the past 10 years
Min: 15.93, Med: 35.71, Max: 125
Current: 23.92
15.93
125
Price-to-Owner-Earnings 29.14
Price-to-Owner-Earnings ranked lower than
71.08% of 83 companies
in the Medical Instruments & Supplies industry.
Industry Max: 631.1, Med: 30.92, Min: 1.32
LMAT: 29.14
Ranked among companies with meaningful Price-to-Owner-Earnings only.
Price-to-Owner-Earnings range over the past 10 years
Min: 12.22, Med: 38.83, Max: 3485
Current: 29.14
12.22
3485
PB Ratio 4.04
PB Ratio ranked lower than
79.27% of 193 companies
in the Medical Instruments & Supplies industry.
Industry Max: 53.91, Med: 3.45, Min: 0.13
LMAT: 4.04
Ranked among companies with meaningful PB Ratio only.
PB Ratio range over the past 10 years
Min: 0.67, Med: 2.04, Max: 7.08
Current: 4.04
0.67
7.08
PS Ratio 4.95
PS Ratio ranked lower than
80.21% of 192 companies
in the Medical Instruments & Supplies industry.
Industry Max: 720.69, Med: 3.48, Min: 0.08
LMAT: 4.95
Ranked among companies with meaningful PS Ratio only.
PS Ratio range over the past 10 years
Min: 0.62, Med: 1.91, Max: 7.93
Current: 4.95
0.62
7.93
Price-to-Free-Cash-Flow 44.50
Price-to-Free-Cash-Flow ranked lower than
72.97% of 74 companies
in the Medical Instruments & Supplies industry.
Industry Max: 794.44, Med: 28.61, Min: 0.95
LMAT: 44.5
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
Price-to-Free-Cash-Flow range over the past 10 years
Min: 9.2, Med: 34.8, Max: 112.19
Current: 44.5
9.2
112.19
Price-to-Operating-Cash-Flow 34.66
Price-to-Operating-Cash-Flow ranked lower than
74.47% of 94 companies
in the Medical Instruments & Supplies industry.
Industry Max: 807.55, Med: 21.15, Min: 0.86
LMAT: 34.66
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
Price-to-Operating-Cash-Flow range over the past 10 years
Min: 8.29, Med: 24.34, Max: 63.61
Current: 34.66
8.29
63.61
EV-to-EBIT 17.23
EV-to-EBIT ranked lower than
71.90% of 121 companies
in the Medical Instruments & Supplies industry.
Industry Max: 126.36, Med: 23.93, Min: 0.21
LMAT: 17.23
Ranked among companies with meaningful EV-to-EBIT only.
EV-to-EBIT range over the past 10 years
Min: -48.6, Med: 20.8, Max: 182.5
Current: 17.23
-48.6
182.5
EV-to-EBITDA 14.81
EV-to-EBITDA ranked lower than
73.91% of 138 companies
in the Medical Instruments & Supplies industry.
Industry Max: 614.98, Med: 19.49, Min: 0.2
LMAT: 14.81
Ranked among companies with meaningful EV-to-EBITDA only.
EV-to-EBITDA range over the past 10 years
Min: -33.7, Med: 14.7, Max: 73.6
Current: 14.81
-33.7
73.6
EV-to-Revenue 4.43
EV-to-Revenue ranked lower than
74.87% of 199 companies
in the Medical Instruments & Supplies industry.
Industry Max: 4881, Med: 3.57, Min: 0.12
LMAT: 4.43
Ranked among companies with meaningful EV-to-Revenue only.
EV-to-Revenue range over the past 10 years
Min: 0.2, Med: 1.6, Max: 7.6
Current: 4.43
0.2
7.6
PEG Ratio 0.85
PEG Ratio ranked higher than
60.87% of 69 companies
in the Medical Instruments & Supplies industry.
Industry Max: 112.54, Med: 2.7, Min: 0.05
LMAT: 0.85
Ranked among companies with meaningful PEG Ratio only.
PEG Ratio range over the past 10 years
Min: 0.7, Med: 1.73, Max: 4.37
Current: 0.85
0.7
4.37
Shiller PE Ratio 55.15
Shiller PE Ratio ranked lower than
94.44% of 54 companies
in the Medical Instruments & Supplies industry.
Industry Max: 600, Med: 50.97, Min: 0.42
LMAT: 55.15
Ranked among companies with meaningful Shiller PE Ratio only.
Shiller PE Ratio range over the past 10 years
Min: 50.64, Med: 124.07, Max: 178
Current: 55.15
50.64
178
Current Ratio 4.92
Current Ratio ranked higher than
85.50% of 200 companies
in the Medical Instruments & Supplies industry.
Industry Max: 30.7, Med: 2.57, Min: 0.1
LMAT: 4.92
Ranked among companies with meaningful Current Ratio only.
Current Ratio range over the past 10 years
Min: 1.39, Med: 5.61, Max: 8.76
Current: 4.92
1.39
8.76
Quick Ratio 3.51
Quick Ratio ranked higher than
82.59% of 201 companies
in the Medical Instruments & Supplies industry.
Industry Max: 30.69, Med: 1.87, Min: -1.52
LMAT: 3.51
Ranked among companies with meaningful Quick Ratio only.
Quick Ratio range over the past 10 years
Min: 0.73, Med: 4.14, Max: 8.76
Current: 3.51
0.73
8.76
Days Inventory 256.51
Days Inventory ranked lower than
78.17% of 197 companies
in the Medical Instruments & Supplies industry.
Industry Max: 876.25, Med: 124.35, Min: 0.86
LMAT: 256.51
Ranked among companies with meaningful Days Inventory only.
Days Inventory range over the past 10 years
Min: 171.21, Med: 221.41, Max: 258.46
Current: 256.51
171.21
258.46
Days Sales Outstanding 52.22
Days Sales Outstanding ranked higher than
64.24% of 165 companies
in the Medical Instruments & Supplies industry.
Industry Max: 655.77, Med: 61.97, Min: 1
LMAT: 52.22
Ranked among companies with meaningful Days Sales Outstanding only.
Days Sales Outstanding range over the past 10 years
Min: 52.22, Med: 55.32, Max: 59.88
Current: 52.22
52.22
59.88
Days Payable 26.24
Days Payable ranked lower than
93.38% of 151 companies
in the Medical Instruments & Supplies industry.
Industry Max: 713.41, Med: 54.66, Min: 2
LMAT: 26.24
Ranked among companies with meaningful Days Payable only.
Days Payable range over the past 10 years
Min: 16.94, Med: 20.56, Max: 33.6
Current: 26.24
16.94
33.6

Dividend & Buy Back

Current vs industry vs history
Dividend Yield % 1.20
Trailing Dividend Yield ranked lower than
77.44% of 164 companies
in the Medical Instruments & Supplies industry.
Industry Max: 106.45, Med: 1.16, Min: 0.01
LMAT: 1.2
Ranked among companies with meaningful Trailing Dividend Yield only.
Trailing Dividend Yield range over the past 10 years
Min: 0.28, Med: 1.18, Max: 1.98
Current: 1.2
0.28
1.98
Dividend Payout Ratio 0.27
Dividend Payout Ratio ranked higher than
95.00% of 100 companies
in the Medical Instruments & Supplies industry.
Industry Max: 10, Med: 0.31, Min: 0.01
LMAT: 0.27
Ranked among companies with meaningful Dividend Payout Ratio only.
Dividend Payout Ratio range over the past 10 years
Min: 0.25, Med: 0.49, Max: 0.63
Current: 0.27
0.25
0.63
3-Year Dividend Growth Rate (Per Share) 20.50
3-Year Dividend Growth Rate ranked higher than
67.74% of 62 companies
in the Medical Instruments & Supplies industry.
Industry Max: 72.6, Med: 8.9, Min: -100
LMAT: 20.5
Ranked among companies with meaningful 3-Year Dividend Growth Rate only.
3-Year Dividend Growth Rate range over the past 10 years
Min: 0, Med: 0, Max: 20.5
Current: 20.5
0
20.5
Forward Dividend Yield % 1.28
Forward Dividend Yield ranked lower than
71.43% of 161 companies
in the Medical Instruments & Supplies industry.
Industry Max: 10.53, Med: 1.3, Min: 0.02
LMAT: 1.28
Ranked among companies with meaningful Forward Dividend Yield only.
N/A
Yield-on-Cost (5-Year) % 2.71
Yield-on-Cost (5y) ranked lower than
56.94% of 209 companies
in the Medical Instruments & Supplies industry.
Industry Max: 106.45, Med: 1.44, Min: 0.01
LMAT: 2.71
Ranked among companies with meaningful Yield-on-Cost (5y) only.
Yield-on-Cost (5y) range over the past 10 years
Min: 0.63, Med: 2.67, Max: 4.47
Current: 2.71
0.63
4.47
3-Year Share Buyback Rate -3.40
3-Year Share Buyback Rate ranked lower than
53.85% of 143 companies
in the Medical Instruments & Supplies industry.
Industry Max: 9.1, Med: -5, Min: -273.3
LMAT: -3.4
Ranked among companies with meaningful 3-Year Share Buyback Rate only.
3-Year Share Buyback Rate range over the past 10 years
Min: -26, Med: -4.2, Max: 1
Current: -3.4
-26
1

Valuation & Return

Current vs industry vs history
Price-to-Tangible-Book 5.96
Price-to-Tangible-Book ranked lower than
77.84% of 167 companies
in the Medical Instruments & Supplies industry.
Industry Max: 3100, Med: 4.77, Min: 0.22
LMAT: 5.96
Ranked among companies with meaningful Price-to-Tangible-Book only.
Price-to-Tangible-Book range over the past 10 years
Min: 1.13, Med: 2.89, Max: 9.86
Current: 5.96
1.13
9.86
Price-to-Projected-FCF 2.05
Price-to-Intrinsic-Value-Projected-FCF ranked lower than
77.33% of 75 companies
in the Medical Instruments & Supplies industry.
Industry Max: 161.65, Med: 2.41, Min: 0.16
LMAT: 2.05
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
Price-to-Intrinsic-Value-Projected-FCF range over the past 10 years
Min: 1.42, Med: 2.14, Max: 3.92
Current: 2.05
1.42
3.92
Price-to-Median-PS-Value 2.61
Price-to-Median-PS-Value ranked lower than
98.13% of 160 companies
in the Medical Instruments & Supplies industry.
Industry Max: 4.9, Med: 1.13, Min: 0.01
LMAT: 2.61
Ranked among companies with meaningful Price-to-Median-PS-Value only.
Price-to-Median-PS-Value range over the past 10 years
Min: 0.39, Med: 1.01, Max: 4
Current: 2.61
0.39
4
Price-to-Peter-Lynch-Fair-Value 0.96
Price-to-Peter-Lynch-Fair-Value ranked higher than
68.89% of 45 companies
in the Medical Instruments & Supplies industry.
Industry Max: 111.95, Med: 2.46, Min: 0.26
LMAT: 0.96
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
Price-to-Peter-Lynch-Fair-Value range over the past 10 years
Min: 0.84, Med: 1.81, Max: 4.2
Current: 0.96
0.84
4.2
Price-to-Graham-Number 2.52
Price-to-Graham-Number ranked lower than
79.79% of 94 companies
in the Medical Instruments & Supplies industry.
Industry Max: 53.19, Med: 2.77, Min: 0.13
LMAT: 2.52
Ranked among companies with meaningful Price-to-Graham-Number only.
Price-to-Graham-Number range over the past 10 years
Min: 1.21, Med: 2.38, Max: 4.63
Current: 2.52
1.21
4.63
Earnings Yield (Joel Greenblatt) % 5.80
Earnings Yield (Greenblatt) ranked higher than
57.97% of 207 companies
in the Medical Instruments & Supplies industry.
Industry Max: 476.19, Med: 2.4, Min: -3333.33
LMAT: 5.8
Ranked among companies with meaningful Earnings Yield (Greenblatt) only.
Earnings Yield (Greenblatt) range over the past 10 years
Min: -29.7, Med: 4.4, Max: 10.9
Current: 5.8
-29.7
10.9
Forward Rate of Return (Yacktman) % 22.10
Forward Rate of Return ranked higher than
93.07% of 101 companies
in the Medical Instruments & Supplies industry.
Industry Max: 28.23, Med: 8.66, Min: -123.3
LMAT: 22.1
Ranked among companies with meaningful Forward Rate of Return only.
Forward Rate of Return range over the past 10 years
Min: -2.3, Med: 10.7, Max: 23
Current: 22.1
-2.3
23

More Statistics

Revenue (TTM) (Mil) $ 108.05
EPS (TTM) $ 1.11
Beta 1.55
Volatility % 47.81
52-Week Range $ 21.79 - 39
Shares Outstanding (Mil) 19.67

Analyst Estimate

Piotroski F-Score Details

Piotroski F-Score 3
Positive ROA Y
Positive CFROA Y
Higher ROA yoy Y
CFROA > ROA N
Lower Leverage yoy N
Higher Current Ratio yoy N
Less Shares Outstanding yoy N
Higher Gross Margin yoy N
Higher Asset Turnover yoy N